Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On October 6, 2024, Maha Katabi, Ph.D., provided notice of her resignation from the board of directors (the "Board") of Aerovate Therapeutics, Inc. (the "Company"), effective as of October 6, 2024. Dr. Katabi also resigned from her positions on the Board's Audit Committee and Compensation Committee. Dr. Katabi resigned voluntarily, and not as a result of any disagreement with the Company on any matter relating to the Company's operations, practices or policies. The Board is grateful to Dr. Katabi for her service and contributions to the Company.